4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(morpholin-4-yl)ethyl]benzamide
Chemical Structure Depiction of
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(morpholin-4-yl)ethyl]benzamide
4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(morpholin-4-yl)ethyl]benzamide
Compound characteristics
Compound ID: | L610-0019 |
Compound Name: | 4-[(5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl)methyl]-N-[2-(morpholin-4-yl)ethyl]benzamide |
Molecular Weight: | 462.55 |
Molecular Formula: | C26 H30 N4 O4 |
Smiles: | C1CC2C(N(Cc3ccc(cc3)C(NCCN3CCOCC3)=O)c3ccccc3C(N2C1)=O)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 0.71 |
logD: | 0.6959 |
logSw: | -2.3297 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 68.419 |
InChI Key: | AZLYNXMUKUVZRH-QHCPKHFHSA-N |